Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.2.9161.4275
Address
Level 12 680 George Street Sydney, New South Wales (NSW) 2000
Description
Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. It manufactures and distributes industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products. The company was founded by Paul Benhaim on September 4, 2017 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.05
Trade Value (12mth)
AU$1,504.00
1 week
-13.33%
1 month
-27.78%
YTD
-67.5%
1 year
-45.83%
All time high
31.85
EPS 3 yr Growth
-96.70%
EBITDA Margin
-21.30%
Operating Cashflow
-$3m
Free Cash Flow Return
-40.10%
ROIC
-19.90%
Interest Coverage
-15.00
Quick Ratio
0.70
Shares on Issue (Fully Dilluted)
221m
HALO Sector
Healthcare
Next Company Report Date
04-Mar-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
19 June 25 |
EXL Announces Leadership Changes
×
EXL Announces Leadership Changes |
11 June 25 |
Notification of cessation of securities - EXL
×
Notification of cessation of securities - EXL |
04 June 25 |
Application for quotation of securities - EXL
×
Application for quotation of securities - EXL |
04 June 25 |
Cleansing Prospectus
×
Cleansing Prospectus |
04 June 25 |
Proposed issue of securities - EXL
×
Proposed issue of securities - EXL |
02 June 25 |
Change of Registered Office
×
Change of Registered Office |
21 May 25 |
EXL raises $1.5M to Accelerate Automation & Brand Growth
×
EXL raises $1.5M to Accelerate Automation & Brand Growth |
21 May 25 |
Proposed issue of securities - EXL
×
Proposed issue of securities - EXL |
21 May 25 |
Reinstatement to Quotation
×
Reinstatement to Quotation |
20 May 25 |
2025 AGM - Chairman's Address
×
2025 AGM - Chairman's Address |
20 May 25 |
2025 AGM - Chairman's Presentation
×
2025 AGM - Chairman's Presentation |
20 May 25 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
19 May 25 |
Extension of Voluntary Suspension
×
Extension of Voluntary Suspension |
15 May 25 |
Suspension from Quotation
×
Suspension from Quotation |
13 May 25 |
Trading Halt
×
Trading Halt |
30 April 25 |
Response to ASX Price Query
×
Response to ASX Price Query |
30 April 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
15 April 25 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
19 March 25 |
Annual General Meeting Date and Director Nominations
×
Annual General Meeting Date and Director Nominations |
28 February 25 |
FY24 Appendix 4E and Annual Report
×
FY24 Appendix 4E and Annual Report |
28 February 25 |
Appendix 4G & Corporate Governance Statement
×
Appendix 4G & Corporate Governance Statement |
28 February 25 |
FY24 Results Announcement
×
FY24 Results Announcement |
28 February 25 |
FY24 Results Presentation
×
FY24 Results Presentation |
31 January 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
08 January 25 |
Notification of cessation of securities - EXL
×
Notification of cessation of securities - EXL |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.